Marker of Brain Insulin Resistance in AD Prognosis

NANot yet recruitingINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2028

Conditions

Prognosis Biomarker of ADMild Cognitive ImpairmentBrain Insuline Resistance

Interventions

BIOLOGICAL

Blood punction

At each annual visit (+/- 3 months), 4X10 mL blood will be taken (1 dry tube, 1 heparinised tube, 2 EDTA tubes)

All Listed Sponsors

collaborator

Thérèse Jonveaux

UNKNOWN

collaborator

Laure Joly

UNKNOWN

lead

Central Hospital, Nancy, France

OTHER

NCT06825663 - Marker of Brain Insulin Resistance in AD Prognosis | Biotech Hunter | Biotech Hunter